New technique traces Alzheimer's-linked lipids in single cells with precision

Researchers at the University of Osaka have developed a groundbreaking technique to trace lipids associated with Alzheimer's disease at the single-cell level. Published on July 8, 2026, in Analytical Chemistry, this innovative method promises to enhance our understanding of neurodegenerative diseases by examining the chemical diversity within cells.

Advancements in Mass Spectrometry Imaging

The new approach improves upon existing methods of mass spectrometry imaging (MSI), specifically using a technique called tapping-mode scanning probe electrospray ionization (t-SPESI). This method allows researchers to analyze cells with pixel sizes as small as 5 micrometers, crucial for studying fine tissue structures.

Lead author Takao Yasuda emphasized the importance of high sensitivity and stability when focusing on smaller areas. The t-SPESI process uses a fine fused silica probe that taps the cell repeatedly, alternating between delivering solvent and extracting chemical components. This innovative design minimizes solvent use while maximizing analytical precision.

Enhancing Sensitivity and Stability

Previous limitations in mass spectrometry imaging included the long distance between the probe and the mass spectrometer, as well as the tendency for cell components to adhere to the probe surface. To overcome these challenges, the research team miniaturized the analytical apparatus, reducing its mass by 45% and shortening the ion pathway by 56%. These adjustments led to a more than twofold increase in signal intensity.

Additionally, the silica probes were coated with a fluorine-containing chemical to reduce sample adhesion, ensuring long-term stability during analyses. This development opens new avenues for exploring the chemical signatures of cells, which are critical for understanding disease progression.

Implications for Disease Research

The team conducted tests on mouse brain tissue samples, successfully visualizing lipid distributions linked to Alzheimer's and Parkinson's disease. The ability to examine cells at such a detailed level is expected to yield new insights into the mechanisms of these neurodegenerative diseases.

Future optimizations of the probe size may further enhance the performance of this technique, potentially transforming how researchers study various disorders. The implications of this technology extend beyond Alzheimer's, offering a powerful tool for advancing our understanding of numerous health conditions.